These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 21145878)

  • 1. Adenosine receptors and brain diseases: neuroprotection and neurodegeneration.
    Gomes CV; Kaster MP; Tomé AR; Agostinho PM; Cunha RA
    Biochim Biophys Acta; 2011 May; 1808(5):1380-99. PubMed ID: 21145878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How does adenosine control neuronal dysfunction and neurodegeneration?
    Cunha RA
    J Neurochem; 2016 Dec; 139(6):1019-1055. PubMed ID: 27365148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenosine A1 and A2A Receptors in the Brain: Current Research and Their Role in Neurodegeneration.
    Stockwell J; Jakova E; Cayabyab FS
    Molecules; 2017 Apr; 22(4):. PubMed ID: 28441750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of knockout mice to explore CNS effects of adenosine.
    Lopes CR; Lourenço VS; Tomé ÂR; Cunha RA; Canas PM
    Biochem Pharmacol; 2021 May; 187():114367. PubMed ID: 33333075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roles of adenosine and its receptors in sleep-wake regulation.
    Huang ZL; Zhang Z; Qu WM
    Int Rev Neurobiol; 2014; 119():349-71. PubMed ID: 25175972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenosine as a neuromodulator and as a homeostatic regulator in the nervous system: different roles, different sources and different receptors.
    Cunha RA
    Neurochem Int; 2001 Feb; 38(2):107-25. PubMed ID: 11137880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Research progress on adenosine in central nervous system diseases.
    Liu YJ; Chen J; Li X; Zhou X; Hu YM; Chu SF; Peng Y; Chen NH
    CNS Neurosci Ther; 2019 Sep; 25(9):899-910. PubMed ID: 31334608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenosine receptors and neurological disease: neuroprotection and neurodegeneration.
    Stone TW; Ceruti S; Abbracchio MP
    Handb Exp Pharmacol; 2009; (193):535-87. PubMed ID: 19639293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenosine A
    Moreira-de-Sá A; Lourenço VS; Canas PM; Cunha RA
    Front Neurosci; 2021; 15():702581. PubMed ID: 34335174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenosine heteroreceptor complexes in the basal ganglia are implicated in Parkinson's disease and its treatment.
    Borroto-Escuela DO; Fuxe K
    J Neural Transm (Vienna); 2019 Apr; 126(4):455-471. PubMed ID: 30637481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenosine receptor control of cognition in normal and disease.
    Chen JF
    Int Rev Neurobiol; 2014; 119():257-307. PubMed ID: 25175970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation and metamodulation of synapses by adenosine.
    Ribeiro JA; Sebastião AM
    Acta Physiol (Oxf); 2010 Jun; 199(2):161-9. PubMed ID: 20345418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenosine receptors and the central nervous system.
    Sebastião AM; Ribeiro JA
    Handb Exp Pharmacol; 2009; (193):471-534. PubMed ID: 19639292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenosine: a prototherapeutic concept in neurodegeneration.
    von Lubitz DK; Carter MF; Beenhakker M; Lin RC; Jacobson KA
    Ann N Y Acad Sci; 1995 Sep; 765():163-78; discussion 196-7. PubMed ID: 7486604
    [No Abstract]   [Full Text] [Related]  

  • 15. Impacts of methylxanthines and adenosine receptors on neurodegeneration: human and experimental studies.
    Chen JF; Chern Y
    Handb Exp Pharmacol; 2011; (200):267-310. PubMed ID: 20859800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenosine receptors in the nervous system: pathophysiological implications.
    Ribeiro JA; Sebastião AM; de Mendonça A
    Prog Neurobiol; 2002 Dec; 68(6):377-92. PubMed ID: 12576292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The adenosine A1 receptor contributes to the stimulatory, but not the inhibitory effect of caffeine on locomotion: a study in mice lacking adenosine A1 and/or A2A receptors.
    Halldner L; Adén U; Dahlberg V; Johansson B; Ledent C; Fredholm BB
    Neuropharmacology; 2004 Jun; 46(7):1008-17. PubMed ID: 15081797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presymptomatic and symptomatic ALS SOD1(G93A) mice differ in adenosine A1 and A2A receptor-mediated tonic modulation of neuromuscular transmission.
    Nascimento F; Sebastião AM; Ribeiro JA
    Purinergic Signal; 2015 Dec; 11(4):471-80. PubMed ID: 26335190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenosine A2A receptors and brain injury: broad spectrum of neuroprotection, multifaceted actions and "fine tuning" modulation.
    Chen JF; Sonsalla PK; Pedata F; Melani A; Domenici MR; Popoli P; Geiger J; Lopes LV; de Mendonça A
    Prog Neurobiol; 2007 Dec; 83(5):310-31. PubMed ID: 18023959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting Adenosine Receptors in Neurological Diseases.
    Atif M; Alsrhani A; Naz F; Imran M; Imran M; Ullah MI; Alameen AAM; Gondal TA; Raza Q
    Cell Reprogram; 2021 Apr; 23(2):57-72. PubMed ID: 33861641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.